Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was introduced to investors on 10 Jul 2019. Dhaval Shah is the Current Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth.The fund currently has an Asset Under Management(AUM) of ₹160 Cr and the Latest NAV as of 18 Oct 2019 is ₹10.30.
The Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is rated High risk. Minimum SIP Investment is 500. Minimum Lumpsum Investment is 1000. Exit load of 0.5% if redeemed within 90 days..
Investment Objective
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
Tax Implications
Scheme Information Document(SID)
₹1000
Min for First Investment
₹1000
Min for Second Investment
Exit load of 0.5% if redeemed within 90 days.
Exit Load